Malaguarnera, M., Vacante, M., Russo, C., Gargante, M. P., Giordano, M., Bertino, G., . . . Volti, G. L. (2011). Rosuvastatin reduces nonalcoholic fatty liver disease in patients with chronic hepatitis C treated with α-interferon and ribavirin: Rosuvastatin reduces NAFLD in HCV patients. Kowsar.
Citación estilo ChicagoMalaguarnera, Michele, et al. Rosuvastatin Reduces Nonalcoholic Fatty Liver Disease in Patients With Chronic Hepatitis C Treated With α-interferon and Ribavirin: Rosuvastatin Reduces NAFLD in HCV Patients. Kowsar, 2011.
Cita MLAMalaguarnera, Michele, et al. Rosuvastatin Reduces Nonalcoholic Fatty Liver Disease in Patients With Chronic Hepatitis C Treated With α-interferon and Ribavirin: Rosuvastatin Reduces NAFLD in HCV Patients. Kowsar, 2011.